AnsweredAssumed Answered

Issue in creating document with rest API

Question asked by kikumar@mdsol.com on Apr 12, 2018
Latest reply on Apr 20, 2018 by john_reynolds

Hi,

I have to convert some HTML pages to jive documents, using nodeJS. Most of the documents created successfully but one document could not be created, even after spending hours, I could not find the reason why other document created successfully but not this one. It will be really helpful if someone here can help

 

Here is the document json:

 

var post_data= {"visibility":"place","subject":"TotalView Release Summary","parent":"/api/core/v3/places/59608","contentTypes":["documents"],"tags":["confluenc

e-newsletter","confluence-migrator","confluence-TotalView","confluence-past-release"],"type":"document","content":{"type":"text/html","text":"<h

2>Page Summary</h2><ol><li><a href=\"#newsletter0\">TotalView 2017.1.0 Release Newsletter</a></li><li><a href=\"#newsletter1\">TotalView 2017.2.

0 Release Newsletter</a></li><li><a href=\"#newsletter2\">TotalView 2017.3.0 Release Newsletter</a></li><li><a href=\"#newsletter3\">TotalView 2

  1. 017.4.0 Release Newsletter</a></li><li><a href=\"#newsletter4\">TotalView 2017.5.0 Release Newsletter</a></li><li><a href=\"#newsletter5\">Total

View 2017.6.0 Release Newsletter</a></li><li><a href=\"#newsletter6\">TotalView 2017.6.1 Release Newsletter</a></li><li><a href=\"#newsletter7\"

>TotalView 2018.1.0 Release Newsletter</a></li><li><a href=\"#newsletter8\">TotalView Universe & Reports 2017.1.1</a></li></ol><a name=\"newslet

ter0\"> </a><h2>TotalView 2017.1.0 Release Newsletter</h2></span></h1><p><span style=\"color: rgb(0,0,0);\">On March 2nd, 2017 Medidata rel

eased the first version of TotalView to the Medidata Platform. <span style=\"color: rgb(0,0,0);\">This </span><span class=\"m_641846005030428949

8gmail-il\" style=\"color: rgb(0,0,0);\">release</span><span style=\"color: rgb(0,0,0);\"> is intended for early adopters only. Full adoption wi

ll start on </span><span class=\"m_6418460050304289498gmail-m_1979773241702437647gmail-aBn\" style=\"color: rgb(0,0,0);\"><span class=\"m_641846

0050304289498gmail-m_1979773241702437647gmail-aQJ\"><span class=\"m_6418460050304289498gmail-aBn\"><span class=\"m_6418460050304289498gmail-aQJ\

"><span class=\"aBn\"><span class=\"aQJ\">March 15, 2017</span></span></span></span></span></span><span style=\"color: rgb(0,0,0);\">. If you wo

uld like to gain access to the TotalView module, please contact your Medidata representative. </span></span></p><p><span style=\"color: rgb(0,0,

0);\"><span style=\"color: rgb(0,0,0);\"> </span>A single destination accessible from </span> <a href=\"http://imedidata.com/\" rel=\"nofollow\"

class=\"external-link\">iMedidata.com <span class=\"fa fa-external-link\"> </span> </a> <span style=\"color: rgb(0,0,0);\">, TotalView will ext

end users’ abilities to generate, explore, and schedule reports with data from across products, studies and URLs.</span> </p><p><span> <span sty

le=\"color: rgb(0,0,0);text-decoration: underline;\">Rollout Plan</span> </span></p><p><span style=\"color: rgb(0,0,0);\">After this initial rel

ease, additional clients will receive TotalView on a rolling basis throughout 2017 with Professional Services driving this process.</span></p><d

iv><span style=\"color: rgb(0,0,0);\"> <br/> </span></div><div><span style=\"color: rgb(0,0,0);\">In Q3 2017, clients will be able to choose bet

ween a Basic and Premium version of TotalView.  The premium version will cost a fee but will allow for additional features, such as ad-hoc repor

ting, that go above-and-beyond those provided in the basic version. <span style=\"color: rgb(0,0,0);\">Adopting TotalView does not automatically

opt-in customers for those premium features</span><span style=\"color: rgb(0,0,0);\">. </span></span></div><div><span style=\"color: rgb(0,0,0)

;\"> <br/> </span></div><div class=\"confluence-information-macro confluence-information-macro-note conf-macro output-block\" data-hasbody=\"tru

e\" data-macro-name=\"note\"><span class=\"aui-icon aui-icon-small aui-iconfont-warning confluence-information-macro-icon\"> </span><div class=\

"confluence-information-macro-body\"><p><span style=\"color: rgb(38,38,38);\">This newsletter provides an early preview into the scope of this r

  1. elease. It is not intended to be as comprehensive as Release Notes. Additional updates may be detailed in the official Release Notes.</span></p>

</div></div><h3 id=\"TotalView2017.1.0ReleaseNewsletter-NewFeatures\">New Features</h3><p><span style=\"color: rgb(0,0,0);\">The top four delive

rables of TotalView 2017.1.0 are:</span></p><p><span> 1) Enhanced data exploration and performance</span></p><ol><li style=\"list-style-type: no

ne;background-image: none;\"><ol><li>Stronger reliability, Faster report generation and fewer timeouts</li><li>More data distribution and export

options</li><li>Expanded edit, filter, calculations and formatting abilities</li><li>Intuitive drag-and-drop interface</li><li>Overall improved

user experience</li></ol></li></ol><div><span> <br/> </span></div><div><span>2) New high value out-of-the-box reports that can be used </span>

<span>as is</span> <span>or configured by clients as they see fit that contains datasets from iMedidata, Balance and Rave from across products/s

tudies:</span></div><ol><ol><li style=\"list-style-type: lower-alpha;\"><p>Cross-Platform Unblinded Detailed Inventory Report:  Gives users’ det

ailed visibility into the location, distribution status, and subject recipient of clinical supplies; a report that provides the ability to bette

r manage inventory needs and ensure that distribution occurred to the correct subjects.  </p></li><li style=\"list-style-type: lower-alpha;\"><p

><span>Cross-Platform </span> <span>Randomization &amp; Trial Supply Management - Subject Report: </span> <span>Provides randomization and treat

ment details for subjects; a report that allows for easy patient review</span></p></li><li style=\"list-style-type: lower-alpha;\"><p><span>Cros

s-Platform </span> <span>Trial Supply Management - Site Report: </span> <span>Provides site information across studies, including total number o

f subjects and shipments; a report that allows users to determine site load. <u>This report needs to be scheduled overnight to generate</u>. </s

pan></p></li><li style=\"list-style-type: lower-alpha;\"><p><span>Cross-Platform Trial Supply Management - Shipments Report: </span> <span>Empow

ers clients to track and filter all shipments across multiple sites and studies; a report that allows users to review shipment statuses</span></

p></li><li style=\"list-style-type: lower-alpha;\"><p><span>Cross-Platform Trial Supply Management - Depot Report: </span> <span>Provides users

with valuable information for depots; a report that allows users to see depot contacts, status and usage information. This report is advised to

be scheduled as may take more than 10 min to generate.</span></p></li><li style=\"list-style-type: lower-alpha;\"><p><span>Organization-Wide E-L

earnings Report:</span> <span> </span> <span>Empowering clients to easily identify e-learning compliance issues and take action</span> <span> ac

ross the organization.</span></p></li><li style=\"list-style-type: lower-alpha;\"><p><span>Organization-Wide Site Access Report: </span> <span>E

mpowering clients to know that the right users are getting assigned to the right studies across the organization. Particularly useful for Mega C

ROs to ensure access is revoked for departing employees across 50+ URLs in a time efficient manner</span></p></li><li style=\"list-style-type: l

ower-alpha;\"><p><span>Organization-Wide Application Access Report: </span> <span>Empowering clients to know that the right users are getting as

signed to the right products across the organization. Particularly useful for Mega CROs to ensure access is revoked for departing employees acro

ss 50+ URLs in a time efficient manner.</span></p></li><li style=\"list-style-type: lower-alpha;\"><p><span>Organization-Wide User Activation St

atus and Profile Report: </span> <span>Clear history of user invitations across the organization, reducing the risk of inadvertent access mistak

  1. es.</span></p></li></ol></ol><div><span> <br/> </span></div><div><span>3) Easily reuse reports on new studies and URLs: </span> <span>New plug a

nd play features that allow clients to reuse their reports on new studies and URLs; no remapping necessary.</span></div><ol><ol><li style=\"list

-style-type: lower-alpha;\"><p><span>Provides significant operational efficiencies by eliminating the laborious process of rebuilding existing r

eports to new studies.</span></p></li><li style=\"list-style-type: lower-alpha;\"><p><span>Removes trial risk caused by potential user error whe

n migrating reports.</span></p></li></ol></ol><p>4) New Platform Infrastructure</p><ol><li style=\"list-style-type: none;background-image: none;

\"><ol><li>Ability to provide information across the Medidata platform - across URLs, studies, and products - at a high rate of velocity to our

customers</li><li>Reduction in operational costs</li></ol></li></ol><h3 id=\"TotalView2017.1.0ReleaseNewsletter-Enhancements\">Enhancements</h3>

<p>N/A</p><h3 id=\"TotalView2017.1.0ReleaseNewsletter-ResolvedIssues\">Resolved Issues</h3><p>None</p><h1 id=\"TotalView2017.1.0ReleaseNewslette

r-<h5><a href=\"https://learn.mdsol.com/display/MCCprd/TotalView+2017.1.0+Release+Newsletter\">Full Newsletter</a></h5><a name=\"newsletter1\">&

nbsp;</a><h2>TotalView 2017.2.0 Release Newsletter</h2></span></h1><p><span style=\"font-size: 24.0px;\"> </span></p><div class=\"confluence-inf

ormation-macro confluence-information-macro-note conf-macro output-block\" data-hasbody=\"true\" data-macro-name=\"note\"><span class=\"aui-icon

aui-icon-small aui-iconfont-warning confluence-information-macro-icon\"> </span><div class=\"confluence-information-macro-body\"><p><span style

=\"color: rgb(38,38,38);\">On April 22, 2017 Medidata will release the second version of TotalView to the Medidata Platform. This release is int

ended to broaden the scope of the report offerings, improve reports' performance and make user access more straightforward. This release also ad

dresses several Known Issues discovered in the initial release. </span></p><p><span style=\"color: rgb(38,38,38);\">Clients interested in receiv

ing TotalView should contact their respective Medidata representative for on-boarding details. </span></p><p><span style=\"color: rgb(0,0,0);\">

TotalView is currently available at no additional charge. There will be OPTIONAL premium (for-charge) features introduced into TotalView in the

  1. future. </span><span style=\"color: rgb(0,0,0);\">Adopting TotalView does not automatically opt-in customers for those premium features</span><s

pan style=\"color: rgb(0,0,0);\">.</span></p></div></div><p> </p><h3 id=\"TotalView2017.2.0ReleaseNewsletter-NewFeatures\">New Features</h3><p>1

) Four new cross-platform customizable out-of-the-box reports:</p><p style=\"margin-left: 30.0px;\">a. Cross-Platform Unblinded Summary Inventor

y Report: <span style=\"color: rgb(0,0,0);\">Provides high-level summary metrics for inventory at depots and sites.</span></p><p style=\"margin-

left: 30.0px;\"><span style=\"color: rgb(0,0,0);\">b</span>. Cross-Platform <span style=\"color: rgb(0,0,0);\">Trial Supply Management: Country

Report - <span style=\"color: rgb(0,0,0);\">Provides high-level summary metrics for countries; including number of sites, assigned depot and QP

release data.</span></span></p><p style=\"margin-left: 30.0px;\"><span style=\"color: rgb(0,0,0);\"><span style=\"color: rgb(0,0,0);\">c. Cross-

Platform <span style=\"color: rgb(0,0,0);\">Trial Supply Management: Lots Report - <span style=\"color: rgb(0,0,0);\">Provides users with valuab

le information for lots; a report that allows users to see lot properties, status and inventory information.</span></span></span></span></p><p s

tyle=\"margin-left: 30.0px;\"><span><span><span><span style=\"color: rgb(0,0,0);\">d. <span style=\"color: rgb(0,0,0);\">Cross-Platform </span><

span style=\"color: rgb(0,0,0);\">Trial Supply Management: Quarantine Report - <span>Provides users with valuable information for quarantines; a

report that allows users to see quarantine dates (open/closed), location and number of items affected. </span></span></span></span></span></spa

n></p><p> </p><p>2) Easier access to TotalView module and Trial Supply Management Reports:</p><ul style=\"list-style-type: square;\"><li>TotalVi

ew Trial Supply Management Reports users are no longer required to log into Balance application to have their Balance permissions propagate to T

  • otalView. Access to Trial Supply Management Reports is now provided once the users accept TotalView invitation provided they have unblinded Bala

nce access. </li></ul><p><strong style=\"font-size: 16.0px;\"><br/></strong></p><p><strong style=\"font-size: 16.0px;\">Enhancements</strong></p

><p>Faster report performance: all reports can now be run on demand with improved rendering times. Trial Supply Management: Site Report no longe

r needs to be scheduled overnight.</p><h3 id=\"TotalView2017.2.0ReleaseNewsletter-ResolvedIssues\">Resolved Issues</h3><div class=\"table-wrap\"

><table class=\"wrapped confluenceTable\"><colgroup> <col/> <col/> </colgroup><tbody><tr><th class=\"confluenceTh\">Issue</th><th class=\"conflu

enceTh\">Description</th></tr><tr><td class=\"confluenceTd\">MCC-284543</td><td class=\"confluenceTd\">The Trial Supply Management - Site Report

takes several hours to generate.</td></tr><tr><td class=\"confluenceTd\">MCC-276561</td><td class=\"confluenceTd\"><p>Users accessing a Balance

Report saved in the shared folder will be able to see the Study and Study Group names for which the report was run, even if they no longer have

access to that study/study group. They will not see any other data.</p></td></tr><tr><td colspan=\"1\" class=\"confluenceTd\">MCC-273221</td><t

d colspan=\"1\" class=\"confluenceTd\">The &quot;Visit&quot; column of the Detailed Inventory Report does not return any data. Visit column shou

ld be populated with the name of the visit during which the subject receives treatment and is left blank for non-dosing visits.</td></tr></tbody

></table></div><h1 id=\"TotalView2017.2.0ReleaseNewsletter-<h5><a href=\"https://learn.mdsol.com/display/MCCprd/TotalView+2017.2.0+Release+Newsl

etter\">Full Newsletter</a></h5><a name=\"newsletter2\"> </a><h2>TotalView 2017.3.0 Release Newsletter</h2></span></h1><p><br/><span class=

\"conf-macro output-inline\" data-hasbody=\"true\" data-macro-name=\"excerpt\"><br/><p></p><div class=\"confluence-information-macro confluence-

information-macro-note conf-macro output-block\" data-hasbody=\"true\" data-macro-name=\"note\"><span class=\"aui-icon aui-icon-small aui-iconfo

nt-warning confluence-information-macro-icon\"> </span><div class=\"confluence-information-macro-body\"><p><span style=\"color: rgb(38,38,38);\"

>On June 23, 2017 Medidata will release the third version of TotalView to the Medidata Platform. </span>TotalView 2017.3.0 is intended to broade

n the scope of report offerings, improve reports' performance and enable additional functionality for the Trial Supply Management Reports. 

</p><p><span style=\"color: rgb(38,38,38);\">Clients interested in receiving TotalView should contact their respective Medidata representative f

or on-boarding details.</span></p><p><span style=\"color: rgb(0,0,0);\">TotalView is currently available at no additional charge. Ther

e will be OPTIONAL premium (for-charge) features introduced into TotalView in the future. </span><span style=\"color: rgb(0,0,0);\">Ad

opting TotalView does not automatically opt-in customers for those premium features</span><span style=\"color: rgb(0,0,0);\">.</span><

/p></div></div><h3 id=\"TotalView2017.3.0ReleaseNewsletter-NewFeatures\">New Features</h3><p>1) New cross-platform customizable out-of-the-box r

eport:</p><ul><li><strong><span style=\"color: rgb(0,0,0);\">Cross-Platform </span><span style=\"color: rgb(0,0,0);\">Trial Supply Manageme

nt: Supply Plan Report </span></strong>- Provides users with valuable information on supply plans; a report that shows all supply plan conf

iguration settings. </li></ul><p>2) New TotalView report feature:</p><ul><li><strong><strong>Adding Address to Trial Supply Management: Sit

e Report</strong></strong> -<strong><strong> </strong></strong>Adding Site Address to Site report would improve operational efficiency of users

tracking site information within TotalView and Balance. Address includes full street address, country, state, city and zip code where applicable

. </li></ul><p>3) New TotalView reporting module feature:</p><ul><li><strong>Input Controls</strong> - Functionality within TotalView enabl

ing users to quickly limit the report output by selecting the appropriate input parameters after the report has run. This functionality works si

milarly to the filtering one, but is more intuitive and requires fewer clicks to narrow-down the resulting data set. Input controls are accessib

le on the left-hand side of TotalView interface and are multi-select and do not cascade.</li></ul><h3 id=\"TotalView2017.3.0ReleaseNew

sletter-Enhancements\">Enhancements</h3><p>Faster report performance: all reports can now be run on demand with improved rendering times. Organi

zation-Wide eLearning Compliance Report can now be run in under a minute for multiple studies.</p><h3 id=\"TotalView2017.3.0ReleaseNewsletter-Re

solvedIssues\">Resolved Issues</h3><div class=\"table-wrap\"><table class=\"wrapped confluenceTable\"><colgroup><col/><col/></colgroup><tbody><t

r><th class=\"confluenceTh\">Issue</th><th class=\"confluenceTh\">Description</th></tr><tr><td class=\"confluenceTd\"><p>MCC-273864</p></td><td

class=\"confluenceTd\">TotalView Folder Permissions.</td></tr></tbody></table></div><p><br/></p><p> </p><h5><a href=\"https://learn.mdsol.c

om/display/MCCprd/TotalView+2017.3.0+Release+Newsletter\">Full Newsletter</a></h5><hr/><a name=\"newsletter3\"> </a><h2>TotalView 2017.4.0

Release Newsletter</h2></h1><p><br/><span class=\"conf-macro output-inline\" data-hasbody=\"true\" data-macro-name=\"excerpt\"><br/><p></p><div

class=\"confluence-information-macro confluence-information-macro-note conf-macro output-block\" data-hasbody=\"true\" data-macro-name=\"note\">

<span class=\"aui-icon aui-icon-small aui-iconfont-warning confluence-information-macro-icon\"> </span><div class=\"confluence-information-macro

-body\"><p><span style=\"color: rgb(38,38,38);\">On October 27, 2017 Medidata will release the 4th release of TotalView to the Medidata Platform

. </span></p><p>With TotalView 2017.4.0, Medidata is adding 3 Site Monitoring and 1 Issue Management operational reports to support the rol

l out of the Strategic Monitoring Module. The new reporting tool will include standardized metadata that will help clients clearly see how data

from multiple products on a given study or multiple studies link together based on a common source of truth. By using this unified, mastered dat

a, TotalView 2017.4.0 users will gain deeper reporting insights and support the operations of the Strategic Monitoring Module.</p><p><span style

=\"color: rgb(38,38,38);\">Clients interested in receiving TotalView should contact their respective Medidata representative for on-boarding det

  1. ails.</span></p><p><span style=\"color: rgb(0,0,0);\">TotalView is currently available at no additional charge. There will be OPTIONAL

premium (for-charge) features introduced into TotalView in the future. </span><span style=\"color: rgb(0,0,0);\">Adopting TotalV

iew does not automatically opt-in customers for those premium features</span><span style=\"color: rgb(0,0,0);\">.</span></p></div></div><h3

id=\"TotalView2017.4.0ReleaseNewsletter-NewFeatures\">New Features</h3><p>New customizable out-of-the-box Strategic Monitoring reports:</p><ul>

<li><p><strong>Site Monitoring Summary and Metrics Report</strong> <span style=\"font-size: 16.0px;\"><span style=\"font-size: 16.0px;\">-</span

></span><span style=\"font-size: 16.0px;\"><span style=\"font-size: 16.0px;\"> </span></span>this Site Monitoring report is helpful to sponsors

or clinical research organizations (CROs) that want to understand the number and type of deviations occurring within one or many studies. <

/p></li><li><strong>Site Telephone Contact Report</strong> - this Site Monitoring report helps identify the key stakeholders and their contact i

nformation at one or many sites and studies via TotalView. </li></ul><div><ul><li><strong>Site Monitor Visit Metrics Repo</strong>rt - this

Site Monitoring report will be used to assess the CRAs' performance from within TotalView. This report has two sections: (1) a summary of appro

ved CRA visit report statistics and (2) details of CRA visit report submissions and corrections.</li><li><strong>Issues and Protocol Deviations

Report</strong> - this Issue Management report will be used within TotalView to see a table of all site and subject deviations entered for a stu

dy or across studies.</li></ul></div><h3 id=\"TotalView2017.4.0ReleaseNewsletter-ResolvedIssues\">Resolved Issues</h3><p></p><div class=\"table-

wrap\"><table class=\"wrapped relative-table confluenceTable\" style=\"width: 55.819%;\"><colgroup><col style=\"width: 14.9292%;\"/><col style=\

"width: 85.045%;\"/></colgroup><tbody><tr><th class=\"confluenceTh\">Issue</th><th class=\"confluenceTh\">Description</th></tr><tr><td class=\"c

onfluenceTd\"><p>MCC-303024</p></td><td class=\"confluenceTd\"><p>Fields using double-byte characters (Chinese, Japanese, and Korean) <br/>are n

ot displayed properly in the TotalView reports. They are displayed as question mark (?) characters.</p></td></tr></tbody></table></div><p><br/><

/p><p> </p><h5><a href=\"https://learn.mdsol.com/display/MCCprd/TotalView+2017.4.0+Release+Newsletter\">Full Newsletter</a></h5><hr/><a nam

e=\"newsletter4\"> </a><h2>TotalView 2017.5.0 Release Newsletter</h2></span></h1><p><br/><span class=\"conf-macro output-inline\" data-hasb

ody=\"true\" data-macro-name=\"excerpt\"><br/><p></p><div class=\"confluence-information-macro confluence-information-macro-note conf-macro outp

ut-block\" data-hasbody=\"true\" data-macro-name=\"note\"><span class=\"aui-icon aui-icon-small aui-iconfont-warning confluence-information-macr

o-icon\"> </span><div class=\"confluence-information-macro-body\"><p><span style=\"color: rgb(38,38,38);\">On November 17, 2017 Medidata will re

lease the fifth release of TotalView to the Medidata Platform. </span></p><p>With TotalView 2017.5.0, Medidata is adding a total of eight T

rial Supply Management reports. Three reports will be designated for those users that have &quot;Blinded&quot; access to the Balance application

and were not able to use the Trial Supply Management Reports (Unblinded). This is the first time TotalView reports will become available for th

e &quot;Blinded&quot; users allowing them to realize the benefits of the cross-study and cross-platform reports. Additional five reports are tar

geted for the users of the existing &quot;Unblinded Detailed Inventory&quot; and &quot;Unblinded Summary Inventory&quot; reports and deliver <sp

an>focused value without having the distraction of multiple tabs in the reports. Clients can choose to view / schedule / customize the informati

on that is most important to them - without having information overload that the complete report could represent. </span></p><p><span style

=\"color: rgb(38,38,38);\">Clients interested in receiving TotalView should contact their respective Medidata representative for on-boarding det

  1. ails.</span></p><p><span style=\"color: rgb(0,0,0);\">TotalView is currently available at no additional charge. There will be OPTIONAL

premium (for-charge) features introduced into TotalView in the future. </span><span style=\"color: rgb(0,0,0);\">Adopting TotalV

iew does not automatically opt-in customers for those premium features</span><span style=\"color: rgb(0,0,0);\">.</span></p></div></div><h3

id=\"TotalView2017.5.0ReleaseNewsletter-NewFeatures\">New Features</h3><p><strong>New customizable out-of-the-box Trial Supply Management Repor

ts</strong> :</p><ul><li><strong><strong>Trial Supply Management: Country Report (Blinded) </strong></strong>- <span style=\"color: rgb(0,0,0);\

">The report provides users with QP, depot, and site information by country across studies; a report that allows users to see valuable informati

on about countries in a study. Country data contained within the report is at the study and study group level. This report is intended

for use by both blinded and unblinded users.</span><strong><br/></strong></li><li><span style=\"color: rgb(0,0,0);\"><strong><strong>Trial Supp

ly Management: Depot Report (Blinded) </strong></strong>- <span style=\"color: rgb(0,0,0);\">This report provides users with more visibility int

o the details describing activity and inventory per depot. Depot data contained within the report is at the study and study group level. This re

port is intended to be used by both unblinded and blinded users and as such excludes inventory information.</span><strong><strong><span style=\"

color: rgb(0,0,0);\"> </span></strong></strong><br/></span></li><li><strong>Trial Supply Management: Site Report (Blinded)</strong> - 

<span style=\"color: rgb(0,0,0);\">This report provides users with more visibility into the details describing a particular site. Site data cont

ained within the report is at the study and study group level. This report is intended to be used by both unblinded and blinded users and as suc

h excludes inventory information. </span></li><li><span style=\"color: rgb(0,0,0);\"><span style=\"color: rgb(0,0,0);\"><strong>Additional Trial

Supply Management Reports</strong> - Deliver</span><span style=\"color: rgb(0,0,0);\"><span style=\"color: rgb(0,0,0);\"> focused value for the

users of the Inventory Reports by removing the distraction of other tabs in the report. Clients can choose to view / schedule / customize the i

nformation that is most important to them - without having information overload that the complete report could represent. Five reports will be d

elivered:</span></span><br/></span><ul><li>Unblinded Summary Inventory Report - Depot Only</li><li>Unblinded Summary Inventory Report - Site Inv

entory Only</li><li>Unblinded Summary Inventory Report - Study Only</li><li>Unblinded Detailed Inventory Report - Numbered Only</li><li>Unblinde

d Detailed Inventory Report - Unnumbered Only</li></ul></li></ul><p><br/></p><h3 id=\"TotalView2017.5.0ReleaseNewsletter-Enhancements\">Enhancem

ents</h3><p>None</p><p><br/></p><p></p><h5><a href=\"https://learn.mdsol.com/display/MCCprd/TotalView+2017.5.0+Release+Newsletter\">Full Newslet

ter</a></h5><hr/><a name=\"newsletter5\"> </a><h2>TotalView 2017.6.0 Release Newsletter</h2></span></h1><p><br/><span class=\"conf-macro ou

tput-inline\" data-hasbody=\"true\" data-macro-name=\"excerpt\"><br/><p></p><div class=\"confluence-information-macro confluence-information-mac

ro-note conf-macro output-block\" data-hasbody=\"true\" data-macro-name=\"note\"><span class=\"aui-icon aui-icon-small aui-iconfont-warning conf

luence-information-macro-icon\"> </span><div class=\"confluence-information-macro-body\"><p><span style=\"color: rgb(38,38,38);\">On December 15

, 2017 Medidata will release the 6th version of TotalView to the Medidata Platform. </span></p><p><span style=\"color: rgb(38,38,38);\">Cli

ents interested in receiving TotalView should contact their respective Medidata representative for on-boarding details.</span></p><p><span style

=\"color: rgb(0,0,0);\">TotalView is currently available at no additional charge. There will be OPTIONAL premium (for-charge) fea

tures introduced into TotalView in the future. </span><span style=\"color: rgb(0,0,0);\">Adopting TotalView does not automatically opt

-in customers for those premium features</span><span style=\"color: rgb(0,0,0);\">.</span></p></div></div><h3 id=\"TotalView2017.6.0Release

Newsletter-NewFeatures\">New Features</h3><p>New customizable out-of-the-box reports:</p><ul><li><s><strong>Coding Decisions Report </strong>-&n

bsp;<span style=\"color: rgb(0,0,0);\">displays coding tasks that are successfully coded and assigned to medical dictionary terms. The report re

trieves the current workflow status of a specific coded term or all coded terms in a specific study, and, when specified, it indicates whether a

uto-coding was attempted.</span><span style=\"color: rgb(255,255,255);\"> </span></s><span style=\"color: rgb(255,255,255);\"><span style=\"colo

r: rgb(38,50,56);\">The TotalView Coding Decisions Report is being removed from the TotalView 2017.6.0 The report will be made available to the

end users at a future date pending the future Coder release. </span></span><br/><span style=\"color: rgb(255,255,255);\"><span style=\"color: rg

b(38,50,56);\"><br/></span></span></li><li><strong>Rave to Safety Gateway E2B Comparison Report</strong> - <span style=\"color: rgb(0,0,0);

\">provides users a method to review and determine what has changed between its current mappings and its previous mappings as part of safety pro

cess reviews. By providing the Rave to Safety Gateway E2B Comparison Report, users will no longer need to generate custom reports, and can elimi

nate manual reconciliation of changes between versions of mappings.</span></li></ul><p>4 Strategic Monitoring reports now honor the blinding per

missions of the Strategic Monitoring users that access them. The 4 reports are:</p><ul><li><p><strong>Site Monitoring Summary and Metrics Report

 </strong><span><span>-</span></span><span><span> </span></span>this Site Monitoring report is helpful to sponsors or clinical researc

h organizations (CROs) that want to understand the number and type of deviations occurring within one or many studies. </p></li><li><strong

>Site Telephone Contact Report</strong> - this Site Monitoring report helps identify the key stakeholders and their contact information at

one or many sites and studies via TotalView. </li><li><strong>Site Monitor Visit Metrics Report</strong> - this Site Monitoring report will

be used to assess the CRAs' performance from within TotalView. This report has two sections: (1) a summary of approved CRA visit report statist

ics and (2) details of CRA visit report submissions and corrections.</li><li><strong>Issues and Protocol Deviations Report</strong> - this

Issue Management report will be used within TotalView to see a table of all site and subject deviations entered for a study or across studies.</

li></ul><h3 id=\"TotalView2017.6.0ReleaseNewsletter-Enhancements\">Enhancements</h3><ul><li><strong>Issue and Protocol Deviations Report</strong

> - Removed &quot;Reported Date&quot; column from the report as it represents the same information as &quot;Created Date&quot; effecti

vely making it a duplicate (MCC-339594).</li></ul><h3 id=\"TotalView2017.6.0ReleaseNewsletter-ResolvedIssues\">Resolved Issues</h3><div class=\"

table-wrap\"><table class=\"wrapped relative-table confluenceTable\" style=\"width: 42.6514%;\"><colgroup><col style=\"width: 17.6211%;\"/><col

style=\"width: 82.3655%;\"/></colgroup><tbody><tr><th class=\"confluenceTh\">Issue</th><th class=\"confluenceTh\">Description</th></tr><tr><td c

lass=\"confluenceTd\"><p>MCC-337864</p></td><td class=\"confluenceTd\"><span>Country Column Not Available in the Issues and Protocol Deviations

Report</span></td></tr><tr><td class=\"confluenceTd\">MCC-339265</td><td class=\"confluenceTd\"><p><span>Report Prompts Include Studies not Link

ed to Strategic Monitoring</span></p></td></tr><tr><td colspan=\"1\" class=\"confluenceTd\"><p>MCC-336010</p></td><td colspan=\"1\" class=\"conf

luenceTd\"><span>Primary Investigator Blank Values in all 4 Strategic Monitoring Reports</span></td></tr></tbody></table></div><p></p><p> <

/p><h5><a href=\"https://learn.mdsol.com/display/MCCprd/TotalView+2017.6.0+Release+Newsletter\">Full Newsletter</a></h5><hr/><a name=\"newslette

r6\"> </a><h2>TotalView 2017.6.1 Release Newsletter</h2></span></h1><p><br/><span class=\"conf-macro output-inline\" data-hasbody=\"true\"

data-macro-name=\"excerpt\">This release of TotalView 2017.6.1 contains the following changes.<p></p><div class=\"confluence-information-macro c

onfluence-information-macro-note conf-macro output-block\" data-hasbody=\"true\" data-macro-name=\"note\"><span class=\"aui-icon aui-icon-small

aui-iconfont-warning confluence-information-macro-icon\"> </span><div class=\"confluence-information-macro-body\"><p><span style=\"color: rgb(38

,38,38);\">On January 31, 2018 Medidata will release the 7th version of TotalView to the Medidata Platform. </span></p><p><span style=\"col

or: rgb(38,38,38);\">Clients interested in receiving TotalView should contact their respective Medidata representative for on-boarding details.<

/span></p><p><span style=\"color: rgb(0,0,0);\">TotalView is currently available at no additional charge. There will be OPTIONAL premi

um (for-charge) features introduced into TotalView in the future. </span><span style=\"color: rgb(0,0,0);\">Adopting TotalView do

es not automatically opt-in customers for those premium features</span><span style=\"color: rgb(0,0,0);\">.</span></p></div></div><h3 id=\"

TotalView2017.6.1ReleaseNewsletter-NewFeatures\">New Features</h3><p><span style=\"color: rgb(38,38,38);\">New customizable out-of-the-box repor

t:</span></p><ul><li><strong>Coding Decisions Report</strong> - <span style=\"color: rgb(0,0,0);\">displays coding tasks that are succ

essfully coded and assigned to medical dictionary terms. The report retrieves the current workflow status of a specific coded term or all coded

terms in a specific study, and, when specified, it indicates whether auto-coding was attempted.</span><span style=\"color: rgb(255,255,255);\">&

nbsp;</span></li></ul><h3 id=\"TotalView2017.6.1ReleaseNewsletter-Enhancements\">Enhancements</h3><ul><li><strong>Strategic Monitoring Reports <

/strong> - Prompts summary box in all four Strategic Monitoring reports will now include the Client Division Scheme for which the repo

rt was run.</li><li><strong>Trial Supply Management: Subject Report</strong> - removed Treatment Composition column to align with the

subject download in Balance application.</li></ul><p><br/></p><p></p><p> </p><h5><a href=\"https://learn.mdsol.com/display/MCCprd/TotalView

+2017.6.1+Release+Newsletter\">Full Newsletter</a></h5><hr/><a name=\"newsletter7\"> </a><h2>TotalView 2018.1.0 Release Newsletter</h2></sp

an></h1><p><span style=\"color: rgb(38,38,38);\">On March 27, 2018 Medidata will release the 9th version of TotalView to the Medidata Platform.

The highlight of this release is the application localization. Localization will enable our APAC customers to interact with the TotalView platfo

rm in Japanese, Korean and Chinese. TotalView reporting interface, as well as some report columns (no translation of the actual report output),

will be translated allowing for a better user experience and promoting TotalView adoption among APAC clients. Along with the localization, a num

ber of Known Issues are being addressed - please see resolved issues list for more details. </span></p><p><span style=\"color: rgb(38,38,38);\">

Clients interested in receiving TotalView should contact their respective Medidata representative for on-boarding details. </span><span style=\"

color: rgb(0,0,0);\">TotalView is available at no additional charge.</span></p><p><span style=\"font-size: 16.0px;font-weight: bold;\"><br/></sp

an></p><p><span style=\"font-size: 16.0px;font-weight: bold;\">New Features</span></p><p><span style=\"font-size: 16.0px;font-weight: bold;\"><b

r/></span></p><p><br/></p><ul><li><strong>TotalView Application Localization</strong> - when a user updates the locale in their iMedidata profil

e to either JPN, CHN or KOR, upon accessing TotalView, user interface and TotalView launchpad will be displayed in the corresponding APAC langua

ge for the appropriate environment.</li><li><strong>Integrate &quot;Help&quot; link with the Knowledge Space - </strong>on clicking “Help” withi

n TotalView, instead of SAP's support page, user will land on the TotalView Knowledge Space. </li></ul><p><br/></p><h3 id=\"TotalView2018.1.0Rel

easeNewsletter-Enhancements\">Enhancements</h3><ul><li><strong>Added new statuses to the Trial Supply Management reports</strong> - instead of s

howing a generic status of &quot;Other&quot;, the following statuses will be displayed aligning with the ones in the Balance application:</li></

ul><ul><li style=\"list-style-type: none;background-image: none;\"><ul><li>Returned from Subject</li><li>Not Returned from Subject</li><li>Recon

ciled at Site</li><li>In Reconciliation</li><li>Destroyed at Site<br/><br/></li></ul></li><li><strong>Updated Blinding Logic in the Strategic Mo

nitoring Reports - </strong>updated the way Strategic Monitoring reports in TotalView display unblinded/blinded records/visits/actions to align

with the latest updates in the Strategic Monitoring suite. </li></ul><h3 id=\"TotalView2018.1.0ReleaseNewsletter-ResolvedIssues\">Resolved Issue

s</h3><div class=\"table-wrap\"><table class=\"relative-table confluenceTable\" style=\"width: 46.9218%;\"><colgroup><col style=\"width: 15.3846

%;\"/><col style=\"width: 84.6154%;\"/></colgroup><tbody><tr><th class=\"confluenceTh\">MCC #</th><th class=\"confluenceTh\">Description</th></t

r><tr><td class=\"confluenceTd\"><p>MCC-292496</p></td><td class=\"confluenceTd\"><span>TSM Summary Inventory Report (Site Inventory View): Site

s with no inventory are NOT displayed</span></td></tr><tr><td colspan=\"1\" class=\"confluenceTd\"><p>MCC-296081</p></td><td colspan=\"1\" class

=\"confluenceTd\"><span>TSM Supply Plan Report: Pooling Group Discrepancies</span></td></tr><tr><td colspan=\"1\" class=\"confluenceTd\"><p>MCC-

291276</p></td><td colspan=\"1\" class=\"confluenceTd\">TV: Supply Plan Report: N/A values not displaying in report</td></tr><tr><td colspan=\"1

\" class=\"confluenceTd\"><p>MCC-305810</p></td><td colspan=\"1\" class=\"confluenceTd\">TSM - Supply Plan Report - Row/Column Differences Betwe

en TV view and Balance UI</td></tr><tr><td colspan=\"1\" class=\"confluenceTd\"><p>MCC-354494</p></td><td colspan=\"1\" class=\"confluenceTd\"><

span>When a User is Unassigned from a TotalView - Report Data Access Role, the Folder is Still Displayed</span></td></tr><tr><td colspan=\"1\" c

lass=\"confluenceTd\"><p>MCC-359566</p></td><td colspan=\"1\" class=\"confluenceTd\"><span>Non-English Locales are not Supported in TotalView</s

pan></td></tr></tbody></table></div><p><br/></p><p><span style=\"color: rgb(0,0,0);\"><br/></span></p><h1 id=\"TotalView2018.1.0ReleaseNewslette

r-<h5><a href=\"https://learn.mdsol.com/display/MCCprd/TotalView+2018.1.0+Release+Newsletter\">Full Newsletter</a></h5><a name=\"newsletter8\">&

nbsp;</a><h2>TotalView Universe & Reports 2017.1.1</h2></span></h1><p>This release of TotalView 2017.1.0 contains the following changes.</p><div

class=\"confluence-information-macro confluence-information-macro-note conf-macro output-block\" data-hasbody=\"true\" data-macro-name=\"note\"

><span class=\"aui-icon aui-icon-small aui-iconfont-warning confluence-information-macro-icon\"> </span><div class=\"confluence-information-macr

o-body\"><p><span style=\"color: rgb(38,38,38);\">This newsletter provides an early preview into the scope of this release. It contains the anti

cipated release content and is subject to change. The Scope Highlights is not intended to be as comprehensive as Release Notes. Updates and chan

ges will be detailed in the official Release Notes.</span></p><p><span style=\"color: rgb(38,38,38);\"> </span></p></div></div><h3 id=\"TotalVie

wUniverse&amp;Reports2017.1.1-NewFeatures\">New Features</h3><p></p><ul><li><strong>None</strong></li></ul><h3 id=\"TotalViewUniverse&amp;Report

s2017.1.1-Enhancements\">Enhancements</h3><p></p><ul><li><strong>None</strong></li></ul><h3 id=\"TotalViewUniverse&amp;Reports2017.1.1-ResolvedI

ssues\">Resolved Issues</h3><p></p><div class=\"table-wrap\"><table class=\"wrapped confluenceTable\"><colgroup> <col/> <col/> </colgroup><tbody

><tr><th class=\"confluenceTh\">Issue</th><th class=\"confluenceTh\">Description</th></tr><tr><td class=\"confluenceTd\"><p>MCC-283000</p></td><

td class=\"confluenceTd\">Trial Supply Management: Site Report not returning data</td></tr><tr><td class=\"confluenceTd\"><p>MCC-282998</p></td>

<td class=\"confluenceTd\">Trial Supply Management: Depot Report <span>inconsistently returning no data</span></td></tr></tbody></table></div><h

1 id=\"TotalViewUniverse&amp;Reports2017.1.1-<h5><a href=\"https://learn.mdsol.com/pages/viewpage.action?pageId=100750024\">Full Newsletter</a><

  /h5>"}}

 

 

Instead of returning success message and the document ID it returns:

 

Err:

▼  ♥XmS8↕|

������$0rN♀ {p;♀s♀��T*���JY[��r ↨������f���[>►ՒZ���ni⌂~sv��݅syw��y�����3���zGg����y��*;w���k.♣M{��������h���↑?&{♫F���e΅RRz���X

˙އ_☼kˆ3��j��PD21׋��t|n,'Δ�����8_ov-���G���$∟→Y ����7RT{Gռ̘6}OD���^☻S���<qV��y<wAE2C���9Il���iՊLAkf=��[��͸`I��→▲

 

 

Outcomes